These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 35611774)
21. Cyclodextrin- and dendrimer-conjugated graphene oxide as a nanocarrier for the delivery of selected chemotherapeutic and photosensitizing agents. Siriviriyanun A; Tsai YJ; Voon SH; Kiew SF; Imae T; Kiew LV; Looi CY; Wong WF; Lee HB; Chung LY Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():307-315. PubMed ID: 29752102 [TBL] [Abstract][Full Text] [Related]
22. Polymer grafted magnetic graphene oxide as a potential nanocarrier for pH-responsive delivery of sparingly soluble quercetin against breast cancer cells. Matiyani M; Rana A; Pal M; Rana S; Melkani AB; Sahoo NG RSC Adv; 2022 Jan; 12(5):2574-2588. PubMed ID: 35425302 [TBL] [Abstract][Full Text] [Related]
23. Development of Graphene Oxide-Based Anticancer Drug Combination Functionalized with Folic Acid as Nanocarrier for Targeted Delivery of Methotrexate. Yanikoglu R; Karakas CY; Ciftci F; Insel MA; Karavelioglu Z; Varol R; Yilmaz A; Cakir R; Uvet H; Ustundag CB Pharmaceutics; 2024 Jun; 16(6):. PubMed ID: 38931957 [TBL] [Abstract][Full Text] [Related]
24. Green one-pot synthesis of carboxymethylcellulose/Zn-based metal-organic framework/graphene oxide bio-nanocomposite as a nanocarrier for drug delivery system. Javanbakht S; Pooresmaeil M; Namazi H Carbohydr Polym; 2019 Mar; 208():294-301. PubMed ID: 30658803 [TBL] [Abstract][Full Text] [Related]
25. Redox-responsive hyaluronic acid-functionalized graphene oxide nanosheets for targeted delivery of water-insoluble cancer drugs. Liu J; Zhang D; Lian S; Zheng J; Li B; Li T; Jia L Int J Nanomedicine; 2018; 13():7457-7472. PubMed ID: 30532533 [TBL] [Abstract][Full Text] [Related]
26. Fluorescent graphene oxide via polymer grafting: an efficient nanocarrier for both hydrophilic and hydrophobic drugs. Kundu A; Nandi S; Das P; Nandi AK ACS Appl Mater Interfaces; 2015 Feb; 7(6):3512-23. PubMed ID: 25612470 [TBL] [Abstract][Full Text] [Related]
27. PEGylated nano-graphene oxide as a nanocarrier for delivering mixed anticancer drugs to improve anticancer activity. Pei X; Zhu Z; Gan Z; Chen J; Zhang X; Cheng X; Wan Q; Wang J Sci Rep; 2020 Feb; 10(1):2717. PubMed ID: 32066812 [TBL] [Abstract][Full Text] [Related]
28. GO-PEG as a drug nanocarrier and its antiproliferative effect on human cervical cancer cell line. Bikhof Torbati M; Ebrahimian M; Yousefi M; Shaabanzadeh M Artif Cells Nanomed Biotechnol; 2017 May; 45(3):568-573. PubMed ID: 27027552 [TBL] [Abstract][Full Text] [Related]
29. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide. Yang D; Feng L; Dougherty CA; Luker KE; Chen D; Cauble MA; Banaszak Holl MM; Luker GD; Ross BD; Liu Z; Hong H Biomaterials; 2016 Oct; 104():361-71. PubMed ID: 27490486 [TBL] [Abstract][Full Text] [Related]
30. Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier. Zhou T; Zhou X; Xing D Biomaterials; 2014 Apr; 35(13):4185-94. PubMed ID: 24513318 [TBL] [Abstract][Full Text] [Related]
31. Synthesis of PEGylated nanographene oxide as a nanocarrier for docetaxel drugs and anticancer activity on prostate cancer cell lines. Tas A; Keklikcioglu Cakmak N Hum Exp Toxicol; 2021 Jan; 40(1):172-182. PubMed ID: 32909849 [TBL] [Abstract][Full Text] [Related]
32. Delivery of paclitaxel using PEGylated graphene oxide as a nanocarrier. Xu Z; Zhu S; Wang M; Li Y; Shi P; Huang X ACS Appl Mater Interfaces; 2015 Jan; 7(2):1355-63. PubMed ID: 25546399 [TBL] [Abstract][Full Text] [Related]
33. Functionalized graphene oxide as a nanocarrier for delivering oridonin to improve anti-breast cancer cell activity. Zhang XY; Shi XZ; Yu JY; Wang J; Zhao YM Biomed Chromatogr; 2024 Aug; 38(8):e5943. PubMed ID: 38890009 [TBL] [Abstract][Full Text] [Related]
34. Graphene oxide as a nanocarrier for controlled release and targeted delivery of an anticancer active agent, chlorogenic acid. Barahuie F; Saifullah B; Dorniani D; Fakurazi S; Karthivashan G; Hussein MZ; Elfghi FM Mater Sci Eng C Mater Biol Appl; 2017 May; 74():177-185. PubMed ID: 28254283 [TBL] [Abstract][Full Text] [Related]
35. Dual Drugs Anticancer Nanoformulation using Graphene Oxide-PEG as Nanocarrier for Protocatechuic Acid and Chlorogenic Acid. Bullo S; Buskaran K; Baby R; Dorniani D; Fakurazi S; Hussein MZ Pharm Res; 2019 Apr; 36(6):91. PubMed ID: 31020429 [TBL] [Abstract][Full Text] [Related]
37. Anti-HER2 functionalized graphene oxide as survivin-siRNA delivery carrier inhibits breast carcinoma growth in vitro and in vivo. Wang X; Sun Q; Cui C; Li J; Wang Y Drug Des Devel Ther; 2018; 12():2841-2855. PubMed ID: 30233146 [TBL] [Abstract][Full Text] [Related]
38. Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: a comparative study. Sahoo NG; Bao H; Pan Y; Pal M; Kakran M; Cheng HK; Li L; Tan LP Chem Commun (Camb); 2011 May; 47(18):5235-7. PubMed ID: 21451845 [TBL] [Abstract][Full Text] [Related]
39. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel. Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600 [TBL] [Abstract][Full Text] [Related]
40. Poly(N-vinyl caprolactam) grown on nanographene oxide as an effective nanocargo for drug delivery. Kavitha T; Kang IK; Park SY Colloids Surf B Biointerfaces; 2014 Mar; 115():37-45. PubMed ID: 24316754 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]